UV Light to Lock TB Out of Jail; Shelby First County to Get System That Kills Bacteria in Air CDC Daily UpdateImportant note: Information in this article was accurate in 2000. The state of the art may have changed since the publication date.
Click here to return to CDC Daily Update main menu
DonateNow
Print this article

UV Light to Lock TB Out of Jail; Shelby First County to Get System That Kills Bacteria in Air

Memphis Commercial Appeal (www.memphis.com) (11/21/00) P. B1
Charlier, Tom


Tennessee health officials announced this week that inmates in the Shelby County jail will be protected from airborne bacteria, such as tuberculosis (TB), using new ultraviolet light technology. The Ultraviolet Germicidal Irradiation System, manufactured by Commercial Lighting Design Inc. of Memphis, recycles the indoor air flow through several ultraviolet lights that kill TB-causing bacteria. The system, which is used in water-purification and food-processing systems to reduce the risk of contamination, is being installed in the jail's heating and air-ventilation system. The Shelby County jail will be the first county facility in the nation to have the new system, which costs an estimated $180,000. The project is being sponsored by the Tennessee Valley Authority, the Memphis Light, Gas & Water Division, county government, and the Electric Power Research Institute.
001122
AD002094

Copyright © 2000 - Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.

AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Elton John AIDS Foundation, iMetrikus, Inc., John M. Lloyd Foundation, the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 2000. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2000. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .